Sara Nik

Item: Sara Nik
Rating: 0.63
Author: StockAnalysis.com

Stock Analyst at HC Wainwright & Co.

(0.63)

# 2,814

Out of 4,969 analysts

Total ratings

50%

Success rate

-10.51%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Sara Nik

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	MBRX Moleculin Biotech	Reiterates: Buy	$4	$0.38	+965.25%	1	Aug 27, 2025
	CDTX Cidara Therapeutics	Maintains: Buy	$53 → $74	$63.43	+16.66%	1	Aug 8, 2025

Moleculin Biotech

Aug 27, 2025

Reiterates: Buy

Price Target: $4

Current: $0.38

Upside: +965.25%

Cidara Therapeutics

Aug 8, 2025

Maintains: Buy

Price Target: $53 → $74

Current: $63.43

Upside: +16.66%